PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 2026Case Reports in Cardiology0 citationsOpen Access

Bosutinib‐Associated Cardiac Tamponade: Late‐Onset Treatment‐Emergent Adverse Event—A Case Report

View Full Paper
MOMehmet Ası OktanHDHüseyin DursunYBYelda Deligöz Bildacı

Key Points

  • This case report aims to highlight the relationship between bosutinib and the occurrence of cardiac tamponade.
  • Presented a case of a 63-year-old man
  • Documented onset of cardiac tamponade following bosutinib treatment
  • Monitored related complications including heart failure and acute kidney injury.
  • Patient developed cardiac tamponade and heart failure after bosutinib treatment
  • Acute kidney injury and generalized edema were also reported as complications
  • Findings emphasize the need for monitoring adverse events during therapy.

Abstract

Fluid retention due to tyrosine kinase inhibitor administration might lead to pericardial effusion and right heart failure. Here, we present the case of a 63‐year‐old man with subacute cardiac tamponade complicated with heart failure, acute kidney injury, and generalized edema due to the bosutinib treatment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Oktan et al. (2026) studied this question.

synapsesocial.com/papers/69fa8ef304f884e66b53154fhttps://doi.org/10.1155/cric/6696107
Ask AI
Helpful
Bookmark
Share
View Full Paper